Janssen cardiovascular products

I’m in the interview process and wanted to know which products the cardiovascular reps are responsible for. What Is your thoughts on the products’ impact in the market. Also any other info on the division. Plus and minuses

Any info is appreciated!

 

Liar! Stop phishing for info. You are not interviewing because we are not hiring externals right now. Go screw!

 

Ummm... okay.. thanks for the info. Anyone else have a better answer for me.

Thanks

 

All hires are now done through Syneos Health (inVentiv)

 

#1 Hear of google?

 

Xarelto and Invokana

 

Does anyone know the salary range and bonus package for the CV Specialty position? Capped or uncapped?

Serious replies greatly appreciated.

Thanks in advance

 

Johnson & Johnson and Bayer on Monday announced results of the Phase III MARINER and COMMANDER HF studies at the European Society of Cardiology (ESC) congress and said there were no significant differences found between Xarelto (rivaroxaban) and placebo for the primary efficacy endpoints. In the MARINER trial, Xarelto did not reduce the composite endpoint of venous thromboembolism (VTE) and VTE-related death in high-risk acute medically ill patients following hospital discharge, while in COMMANDER HF, the Factor Xa inhibitor did not impact overall mortality outcomes compared to standard of care. The data were also simultaneously published in the NEJM.

 

Up here in West Virginia we like the CV specialty position but it hurts my sister’s back.....

 

this is probably the laziest post ive ever seen... tell ya what, why dont you make a big massive yuge list of all the janssen cardio products and take a shot in the dark... bet youll hit it.